Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2292 studies found for:    pancreatic cancer
Show Display Options
Rank Status Study
21 Recruiting Exceptional Responders With Pancreatic Cancer to Chemotherapy
Condition: Pancreatic Neoplasms
Intervention: Drug: Standard of care chemotherapy
22 Not yet recruiting Ph II Olaparib for BRCAness Phenotype in Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Drug: Olaparib
23 Completed Triacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic Cancer
Conditions: Drug/Agent Toxicity by Tissue/Organ;   Pancreatic Cancer
Interventions: Drug: fluorouracil;   Drug: gemcitabine hydrochloride;   Drug: triacetyluridine
24 Unknown  Integrated Positron Emission Tomography - Computed Tomography (PET-CT) in Patients With Pancreatic Cancer
Condition: Pancreatic Cancer
25 Recruiting Pancreatic Cancer Screening of High-Risk Individuals in Arkansas
Conditions: Pancreatic Neoplasms;   Peutz-Jegher's Syndrome;   BRCA1 Gene Mutation;   BRCA2 Gene Mutation;   Ataxia Telangiectasia;   Familial Atypical Mole-Malignant Melanoma Syndrome;   Colorectal Neoplasms, Hereditary Nonpolyposis;   Hereditary Pancreatitis
Interventions: Other: Pancreatic Cancer Screening Pathway 1;   Other: Pancreatic Cancer Screening Pathway 2
26 Withdrawn Mirtazapine Plus Gemcitabine Versus Gemcitabine in Metastasis Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: Mirtazapine plus gemcitabine;   Drug: Gemcitabine, placebo
27 Unknown  Human Leukocyte Antigen-A*2402-Restricted Tumor Vessel Specific Peptide Vaccination for Advanced Pancreatic Cancer
Conditions: Pancreatic Cancer;   Pancreas Neoplasms
Intervention: Biological: VEGFR1-A24-1084 (SYGVLLWEI)
28 Recruiting BrUOG 292: FOLFOX-A For Metastatic Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial
Condition: Metastatic Pancreatic Cancer
Intervention: Drug: FOLFOXA
29 Recruiting DCE MRI in Diagnosing Patients With Pancreatic Cancer
Conditions: Hereditary Pancreatic Carcinoma;   Pancreatic Adenocarcinoma;   Pancreatic Intraductal Papillary-Mucinous Neoplasm;   Unresectable Pancreatic Cancer
Intervention: Procedure: Dynamic Contrast-Enhanced Magnetic Resonance Imaging
30 Active, not recruiting Neoadjuvant FIRINOX for Borderline Resectable Pancreatic Cancer - a Pilot Study
Condition: Pancreatic Cancer.
Intervention: Drug: FIRINOX
31 Completed
Has Results
RAD001 in Previously Treated Patients With Metastatic Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Drug: RAD001
32 Completed A Phase III Study of Pancreatic Cancer
Condition: Pancreatic Cancer
33 Recruiting Pancreatic Cancer Genetics
Condition: Pancreatic Cancer
34 Recruiting Combination of Irreversible Electroporation and NK Immunotherapy for Advanced Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Biological: NK cells;   Procedure: irreversible electroporation (IRE )
35 Completed Gemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic Cancer
Condition: Stage IV Pancreatic Cancer
Interventions: Drug: Gemcitabine;   Drug: nab-paclitaxel;   Drug: FOLFIRINOX;   Genetic: Immunohistochemistry (IHC) Analysis;   Drug: Metformin;   Drug: mFOLFIRI
36 Enrolling by invitation International CAPS Registry: Pancreas Cancer Cases in Surveillance Programs
Condition: Pancreas Cancer
37 Completed Gemcitabine With or Without Tipifarnib (R115777) in Treating Patients With Advanced Pancreatic Cancer
Condition: Pancreatic Neoplasms
Interventions: Drug: Gemcitabine with R115777;   Drug: Gemcitabine with Placebo
38 Recruiting Functional Magnetic Resonance Imaging of Pancreatic Cancer: a Feasibility and Reproducibility Study
Condition: Pancreatic Cancer
Intervention: Drug: Gadobutrol
39 Completed Identification of Biomarkers for Early Detection of Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Genetic: protein expression analysis;   Other: laboratory biomarker analysis;   Other: mass spectrometry;   Other: surface-enhanced laser desorption/ionization-time of flight mass spectrometry
40 Enrolling by invitation Electroporation (NanoKnife) as Treatment for Advanced Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Procedure: Electroporation/ Nano knife treatment;   Device: NanoKnife

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years